Leveraging our proprietary muscle stem cell technology combined with precise mRNA-based gene correction, MyoPax is transforming the treatment of muscle disorders. Our portfolio includes tailored regenerative therapies to address muscle defects, genetic muscular dystrophies, and acute muscle wasting – critical unmet medical needs that cause significant loss of personal autonomy and early mortality.
